Jim New

Founder and CEO at WavoDyne Therapeutics - West Henrietta, NY, US

Jim New's Colleagues at WavoDyne Therapeutics
Jim New's Contact Details
HQ
954-632-6630
Location
Fort Lauderdale, Florida, United States
Company
WavoDyne Therapeutics
Jim New's Company Details
WavoDyne Therapeutics logo, WavoDyne Therapeutics contact details

WavoDyne Therapeutics

West Henrietta, NY, US • 5 - 9 Employees
Major Drugs

WavoDyne Therapeutics is a newly founded pharmaceutical company based in Rochester, New York. The company is committed to developing novel therapeutics for patients suffering from cognition and memory impairment associated with neuroinflammation and neurodegeneration. The core technology of WavoDyne is a novel class of small molecule kinase inhibitors that are licensed from the University of Rochester Medical Center (URMC). WavoDyne's primary objective is to advance its leading drug candidate URMC-099 to Phase 2 clinical development for the treatment of Postoperative Cognitive Dysfunction (POCD) and HIV Associated Neurocognitive Disorders (HAND).More information about the company is available at www.wavodyne.com

Neuroinflammation Cognitive Disorders Memory disorders Major Drugs Pharmaceutical Preparations Pharmaceuticals
Details about WavoDyne Therapeutics
Frequently Asked Questions about Jim New
Jim New currently works for WavoDyne Therapeutics.
Jim New's role at WavoDyne Therapeutics is Founder and CEO.
Jim New's email address is ***@wavodyne.com. To view Jim New's full email address, please signup to ConnectPlex.
Jim New works in the Major Drugs industry.
Jim New's colleagues at WavoDyne Therapeutics are and others.
Jim New's phone number is 954-632-6630
See more information about Jim New